STOCK TITAN

AUGO (NASDAQ) insider sales listed, including 188,000-share trade

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

AUGO affiliate reports proposed sale of 55,000 shares of Common Stock. The filing lists the securities to be sold as 55,000 shares (acquired upon option exercise on 03/05/2021). The filing also discloses recent dispositions by the holder: 10,000 shares on 03/17/2026, 10,000 on 03/18/2026, 10,000 on 03/19/2026, 5,000 on 03/20/2026, and 188,000 shares on 05/11/2026.

Positive

  • None.

Negative

  • None.

Insights

Notice of proposed resale under Rule 144 with listed prior sales.

The filing provides a Rule 144 notice for 55,000 shares described as acquired upon an option exercise on 03/05/2021. It also itemizes multiple recent dispositions by the reporting holder, including a 188,000-share sale on 05/11/2026.

Timing and proceeds treatment are not detailed in the excerpt; compliance with holding-period and manner-of-sale requirements will determine whether these shares may be sold under Rule 144 without registration.

Large recent disposals by the holder are visible; market impact depends on trading context.

The excerpt lists five discrete dispositions in March–May 2026, culminating with a 188,000-share sale. The proposed sale of 55,000 shares is recorded separately as securities to be sold.

Whether these transactions affect supply depends on the identity and liquidity of the holder and market conditions; the filing itself does not state how sales were executed.

Proposed resale 55,000 shares acquired upon option exercise on 03/05/2021
Sale on 03/17/2026 10,000 shares disposition by holder on 03/17/2026
Sale on 03/18/2026 10,000 shares disposition by holder on 03/18/2026
Sale on 03/19/2026 10,000 shares disposition by holder on 03/19/2026
Sale on 03/20/2026 5,000 shares disposition by holder on 03/20/2026
Sale on 05/11/2026 188,000 shares disposition by holder on 05/11/2026
Form 144 regulatory
"144: Securities To Be Sold"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
option exercise financial
"Acquired upon option exercise on 03/05/2021"
securities to be sold regulatory
"Securities To Be Sold | Common Stock | 55000"

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does AUGO's Form 144 disclose?

It discloses a proposed resale of 55,000 shares acquired on 03/05/2021, and several past dispositions including 188,000 shares on 05/11/2026.

Who is the reporting holder in this Form 144 for AUGO?

The excerpt lists the reporting holder as Rodrigo Cardoso Barbosa at the provided address and references sales transacted on dates in March–May 2026.

Are the past sales and the proposed sale the same in the filing?

No. The filing lists a separate proposed sale of 55,000 shares and also itemizes prior dispositions of 10,000, 10,000, 10,000, 5,000, and 188,000 shares on specific dates.

Does the Form 144 state how proceeds will be used?

The provided excerpt does not state any use of proceeds or who receives cash from the transactions; proceeds treatment is not included in the visible content.

When were the securities to be sold acquired?

The securities described as to be sold were acquired upon an option exercise on 03/05/2021, as stated in the excerpt.